|
1
|
Cavenee W K, Leung S, Hawkins C, et al:
WHO Classification of Tumours of the Central Nervous System,
Revised. Fourth Edition. WHO Press; Geneva, Switzerland: pp. 28–45.
2016
|
|
2
|
Johnson DR and O'Neill BP: Glioblastoma
survival in the United States before and during the temozolomide
era. J Neurooncol. 107:359–364. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cotrina ML, Lin JH, López-García JC, Naus
CC and Nedergaard M: ATP-mediated glia signaling. J Neurosci.
20:2835–2844. 2000.PubMed/NCBI
|
|
4
|
Zimmermann H: Extracellular metabolism of
ATP and other nucleotides. Naunyn Schmiedebergs Arch Pharmacol.
362:299–309. 2003. View Article : Google Scholar
|
|
5
|
Ciccarelli R, Ballerini P, Sabatino G,
Rathbone MP, D'Onofrio M, Caciagli F and Di Lorio P: Involvement of
astrocytes in purine-mediated reparative processes in the brain.
Int J Dev Neurosci. 19:395–414. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ralevic V and Burnstock G: Receptors for
purines and pyrimidines. Pharmacol Rev. 50:413–492. 1998.PubMed/NCBI
|
|
7
|
Di Virgilio F: Dr. Jekyll/Mr. Hyde: The
dual role of extracellular ATP. J Auton Nerv Syst. 81:59–63. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kim M, Jiang LH, Wilson HL, North RA and
Surprenant A: Proteomic and functional evidence for a P2X7 receptor
signalling complex. EMBO J. 20:6347–6358. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang L, Feng YH and Gorodeski GI:
Epidermal growth factor facilitates epinephrine inhibition of
P2X7-receptor-mediated pore formation and apoptosis: A novel
signaling network. Endocrinology. 146:164–174. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Schneider EM, Vorlaender K, Ma X, Du W and
Weiss M: Role of ATP in trauma-associated cytokine release and
apoptosis by P2X7 ion channel stimulation. Ann NY Acad Sci.
1090:245–252. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bulanova E, Budagian V, Orinska Z, Hein M,
Petersen F, Thon L, Adam D and Bulfone-Paus S: Extracellular ATP
induces cytokine expression and apoptosis through P2X7 receptor in
murine mast cells. J Immunol. 174:3880–3890. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Said T, Dutot M, Christon R, Beaudeux JL,
Martin C, Warnet JM and Rat P: Benefits and side effects of
different vegetable oil vectors on apoptosis, oxidative stress, and
P2X7 cell death receptor activation. Invest Ophthalmol Vis Sci.
48:5000–5006. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Feng YH, Wang L, Wang Q, Li X, Zeng R and
Gorodeski GI: ATP stimulates GRK-3 phosphorylation and
beta-arrestin-2-dependent internalization of P2X7 receptor. Am J
Physiol Cell Physiol. 288:C1342–C1356. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li X, Qi X, Zhou L, Fu W, Abdul-Karim FW,
Maclennan G and Gorodeski GI: P2X(7) receptor expression is
decreased in epithelial cancer cells of ectodermal, uro-genital
sinus and distal paramesonephric duct origin. Purinergic Signal.
5:351–368. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Solini A, Cuccato S, Ferrari D, Santini E,
Gulinelli S, Callegari MG, Dardano A, Faviana P, Madec S, Di
Virgilio F and Monzani F: Increased P2X7 receptor expression and
function in thyroid papillary cancer: A new potential marker of the
disease? Endocrinology. 149:389–396. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fu W, McCormick T, Qi X, Luo L, Zhou L, Li
X, Wang BC, Gibbons HE, Abdul-Karim FW and Gorodeski GI: Activation
of P2X(7)-mediated apoptosis Inhibits DMBA/TPA-induced formation of
skin papillomas and cancer in mice. BMC Cancer. 9:1142009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Greig AV, Linge C, Healy V, Lim P, Clayton
E, Rustin MH, McGrouther DA and Burnstock G: Expression of
purinergic receptors in non-melanoma skin cancers and their
functional roles in A431 cells. J Invest Dermatol. 121:315–327.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li X, Qi X, Zhou L, Catera D, Rote NS,
Potashkin J, Abdul-Karim FW and Gorodeski GI: Decreased expression
of P2X7 in endometrial epithelial pre-cancerous and cancer cells.
Gynecol Oncol. 106:233–243. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lee HY, Bardini M and Burnstock G:
Distribution of P2X receptors in the urinary bladder and the ureter
of the rat. J Urol. 163:2002–2007. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li X, Zhou L, Feng YH, Abdul-Karim FW and
Gorodeski GI: The P2X7 receptor: A novel biomarker of uterine
epithelial cancers. Cancer Epidemiol Biomarkers Prev. 15:1906–1913.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wei W, Ryu JK, Choi HB and McLarnon JG:
Expression and function of the P2X(7) receptor in rat C6 glioma
cells. Cancer Lett. 260:79–87. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fang KM, Wang YL, Huang MC, Sun SH, Cheng
H and Tzeng SF: Expression of macrophage inflammatory protein-1α
and monocyte chemoattractant protein-1 in glioma-infiltrating
microglia: Involvement of ATP and P2X7 receptor. J Neurosci Res.
89:199–211. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ryu JK, Jantaratnotai N, Serrano-Perez MC,
McGeer PL and McLarnon JG: Block of purinergic P2X7R inhibits tumor
growth in a C6 glioma brain tumor animal model. J Neuropathol Exp
Neurol. 70:13–22. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zilberman D and Henikoff S: Genome-wide
analysis of DNA methylation patterns. Development. 134:3959–3965.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Esteller M: CpG island hypermethylation
and tumor suppressor genes: A booming present, a brighter future.
Oncogene. 21:5427–5440. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gómez-Villafuertes R, García-Huerta P,
Díaz-Hernández JI and Miras-Portugal MT: PI3K/Akt signaling pathway
triggers P2X7 receptor expression as a pro-survival factor of
neuroblastoma cells under limiting growth conditions. Sci Rep.
5:184172015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Braganhol E, Kukulski F, Lévesque SA,
Fausther M, Lavoie EG, Zanotto-Filho A, Bergamin LS, Pelletier J,
Bahrami F, Ben Yebdri F, et al: Nucleotide receptors control
IL-8/CXCL8 and MCP-1/CCL2 secretions as well as proliferation in
human glioma cells. Biochim Biophys Acta. 1852:120–130. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Qiu Y, Li WH, Zhang HQ, Liu Y, Tian XX and
Fang WG: P2X7 mediates ATP-driven invasiveness in prostate cancer
cells. PLoS One. 9:e1143712014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fang J, Chen X, Zhang L, Chen J, Liang Y,
Li X, Xiang J, Wang L, Guo G, Zhang B and Zhang W: P2X7R
suppression promotes glioma growth through epidermal growth factor
receptor signal pathway. Int J Biochem Cell Biol. 45:1109–1120.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
White N, Butler PE and Burnstock G: Human
melanomas express functional P2X(7) receptors. Cell Tissue Res.
321:411–418. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bian S, Sun X, Bai A, Zhang C, Li L,
Enjyoji K, Junger WG, Robson SC and Wu Y: P2X7 integrates PI3K/AKT
and AMPK-PRAS40-mTOR signaling pathways to mediate tumor cell
death. PLoS One. 8:e601842013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gehring MP, Kipper F, Nicoletti NF,
Sperotto ND, Zanin R, Tamajusuku AS, Flores DG, Meurer L, Roesler
R, Filho AB, et al: P2X7 receptor as predictor gene for glioma
radiosensitivity and median survival. Int J Biochem Cell Biol.
68:92–100. 2015. View Article : Google Scholar : PubMed/NCBI
|
